• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates.

作者信息

Liang Xuan, Shi Li, Wang Ying, Xiao Wenwei, Duan Guangcai, Yang Haiyan, Wang Yadong

机构信息

Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.

Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.

出版信息

J Infect. 2020 Sep;81(3):e44-e47. doi: 10.1016/j.jinf.2020.06.060. Epub 2020 Jun 25.

DOI:10.1016/j.jinf.2020.06.060
PMID:32593655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7315979/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e5c/7315979/864baa289e44/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e5c/7315979/864baa289e44/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e5c/7315979/864baa289e44/gr1_lrg.jpg

相似文献

1
The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates.高血压与新冠病毒肺炎患者严重程度及死亡率的关联：基于校正效应估计值的证据
J Infect. 2020 Sep;81(3):e44-e47. doi: 10.1016/j.jinf.2020.06.060. Epub 2020 Jun 25.
2
SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.SARS-CoV-2 感染合并糖尿病和高血压的患者：一项系统综述。
Rev Cardiovasc Med. 2020 Sep 30;21(3):385-397. doi: 10.31083/j.rcm.2020.03.78.
3
Arterial hypertension and the risk of severity and mortality of COVID-19.动脉高血压与 COVID-19 严重程度和死亡率的关系。
Eur Respir J. 2020 Jun 11;55(6). doi: 10.1183/13993003.01148-2020. Print 2020 Jun.
4
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因子。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02961-2020. Print 2020 Sep.
5
Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.对于预测新冠病毒疾病（COVID-19）患者的死亡率而言，呼吸困难而非发热是一个风险因素。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.013. Epub 2020 May 15.
6
[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].[2020年，糖尿病和高血压作为墨西哥索诺拉州与新冠病毒致死率相关的因素]
Salud Publica Mex. 2020 Sep-Oct;62(5):456-457. doi: 10.21149/11546.
7
[The novel coronavirus covid-19 pandemic].[新型冠状病毒COVID-19大流行]
Rev Fac Cien Med Univ Nac Cordoba. 2020 Mar 18;77(1):1-3. doi: 10.31053/1853.0605.v77.n1.27935.
8
In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension.在患有高血压的COVID-19患者中，住院期间使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的死亡率和危重症风险相关。
J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.08.014. Epub 2020 Aug 12.
9
[Hypertension and COVID 19: Warnings regarding blood pressure cuffs].[高血压与2019冠状病毒病：关于血压计袖带的警示]
Hipertens Riesgo Vasc. 2020 Jul-Sep;37(3):141-142. doi: 10.1016/j.hipert.2020.05.002. Epub 2020 May 11.
10
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.一名新冠肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):323-324. doi: 10.7326/L20-0894.

引用本文的文献

1
Joint modeling of longitudinal and competing risks for assessing blood oxygen saturation and its association with survival outcomes in COVID-19 patients.用于评估新冠肺炎患者血氧饱和度及其与生存结局关联的纵向和竞争风险联合建模
J Educ Health Promot. 2024 Mar 28;13:91. doi: 10.4103/jehp.jehp_246_23. eCollection 2024.
2
Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia.接种BNT162b2、科兴疫苗或牛津-阿斯利康疫苗后新冠病毒突破性感染病例的临床结局及危险因素：马来西亚的一项回顾性队列研究
Heliyon. 2024 Apr 20;10(8):e29574. doi: 10.1016/j.heliyon.2024.e29574. eCollection 2024 Apr 30.
3

本文引用的文献

1
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.轻症和中度 2019 冠状病毒病患者疾病进展的危险因素：一项多中心观察性研究。
Clin Microbiol Infect. 2020 Sep;26(9):1242-1247. doi: 10.1016/j.cmi.2020.05.041. Epub 2020 Jun 9.
2
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.COVID-19 感染住院患者心肌损伤的患病率和影响。
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546. doi: 10.1016/j.jacc.2020.06.007. Epub 2020 Jun 8.
3
Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.
Prediction models of COVID-19 fatality in nine Peruvian provinces: A secondary analysis of the national epidemiological surveillance system.
秘鲁九个省份新冠病毒病死亡预测模型：国家流行病学监测系统的二次分析
PLOS Glob Public Health. 2024 Jan 29;4(1):e0002854. doi: 10.1371/journal.pgph.0002854. eCollection 2024.
4
Immediate cause and the role of multimorbidity in deaths associated with COVID 19 among hospitalized patients in a low resource district in Kerala India: A record-based case-control analysis.印度喀拉拉邦一个资源匮乏地区住院患者中与新冠病毒病相关死亡的直接原因及多种疾病的作用：基于记录的病例对照分析
J Family Med Prim Care. 2023 Aug;12(8):1593-1601. doi: 10.4103/jfmpc.jfmpc_2061_22. Epub 2023 Aug 29.
5
A Meta-Analysis on the Association between Peptic Ulcer Disease and COVID-19 Severity.消化性溃疡疾病与新型冠状病毒肺炎严重程度关联的Meta分析
Vaccines (Basel). 2023 Jun 11;11(6):1087. doi: 10.3390/vaccines11061087.
6
Health systems interventions for hypertension management and associated outcomes in Sub-Saharan Africa: A systematic review.撒哈拉以南非洲地区高血压管理的卫生系统干预措施及相关结果：一项系统综述。
PLOS Glob Public Health. 2023 Jun 8;3(6):e0001794. doi: 10.1371/journal.pgph.0001794. eCollection 2023.
7
The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches.2019冠状病毒病与类风湿性关节炎的交叉点：共同机制、治疗挑战及潜在治疗方法
Aging Dis. 2023 Aug 1;14(4):1196-1213. doi: 10.14336/AD.2023.0406.
8
Association of Lung Fibrotic Changes and Cardiological Dysfunction with Comorbidities in Long COVID-19 Cohort.长新冠队列中肺纤维化改变和心功能障碍与合并症的关系。
Int J Environ Res Public Health. 2023 Jan 31;20(3):2567. doi: 10.3390/ijerph20032567.
9
Determinants of mortality among hospitalized patients with COVID-19 during first and second waves of the pandemic: A retrospective cohort study from an isolation center in Kano, Nigeria.尼日利亚卡诺隔离中心一项回顾性队列研究：COVID-19 住院患者在大流行第一波和第二波期间的死亡决定因素。
PLoS One. 2023 Feb 6;18(2):e0281455. doi: 10.1371/journal.pone.0281455. eCollection 2023.
10
A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia.与代谢综合征相关的2019冠状病毒病综述：肥胖、高血压、糖尿病和血脂异常
Cureus. 2022 Jul 29;14(7):e27438. doi: 10.7759/cureus.27438. eCollection 2022 Jul.
中国武汉新冠肺炎住院患者的临床特征及死亡风险因素
Clin Transl Med. 2020 Jun;10(2):e40. doi: 10.1002/ctm2.40. Epub 2020 Jun 4.
4
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.代谢功能障碍相关脂肪性肝病及中性粒细胞与淋巴细胞比值升高对新型冠状病毒肺炎严重程度的有害影响。
Diabetes Metab. 2020 Nov;46(6):505-507. doi: 10.1016/j.diabet.2020.06.001. Epub 2020 Jun 4.
5
Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.重症急性肾损伤患者新冠病毒病的致命结局
J Clin Med. 2020 Jun 3;9(6):1718. doi: 10.3390/jcm9061718.
6
Novel coronavirus disease 2019: predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data.新型冠状病毒病 2019：基于计算机断层扫描的疾病严重程度评分和临床实验室数据预测预后。
Pol Arch Intern Med. 2020 Aug 27;130(7-8):629-634. doi: 10.20452/pamw.15422. Epub 2020 Jun 5.
7
Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.2019年冠状病毒病不同年龄段患者的临床特征及预后比较。
Aging (Albany NY). 2020 Jun 4;12(11):10070-10086. doi: 10.18632/aging.103298.
8
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.高血压和降压治疗与 COVID-19 死亡率的关联：一项回顾性观察研究。
Eur Heart J. 2020 Jun 7;41(22):2058-2066. doi: 10.1093/eurheartj/ehaa433.
9
Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.玻利维亚2019冠状病毒病（COVID-19）患者的死亡风险因素：对首批107例确诊病例的分析
Infez Med. 2020 Jun 1;28(2):238-242.
10
COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.COVID-19 合并高血压患者的病情更重：一项多中心回顾性观察研究。
Hypertens Res. 2020 Aug;43(8):824-831. doi: 10.1038/s41440-020-0485-2. Epub 2020 Jun 1.